Amanda Conerty
Sr. Director of CMC at Artiva Biotherapeutics
Amanda Conerty is the Sr. Director of CMC at Artiva Biotherapeutics where she currently heads process development and manufacturing operations for Artiva’s off the shelf NK cell therapy platform. Previously, she was the Sr. Director of Manufacturing and QC at Fate Therapeutics. Amanda has 18 years of cell therapy experience in both clinical and industry.
